Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation

Published:2023-11 Issue: Volume:154 Page:213594
ISSN:2772-9508
Container-title:Biomaterials Advances
language:en
Short-container-title:Biomaterials Advances

Author:

Jadhav Krishna,Jhilta Agrim,Singh Raghuraj,Ray Eupa,Sharma Neleesh,Shukla Rahul,Singh Amit Kumar,Verma Rahul Kumar

Funder

Indian Council of Medical Research

Science and Engineering Research Board

Institute of Nano Science and Technology

Publisher

Elsevier BV

Subject

Biomaterials,Biomedical Engineering,Bioengineering

Reference54 articles.

1. Global Tuberculosis Report 2021: Supplementary Material;W.H. Organization,2022

2. Tuberculosis;Furin;Lancet,2019

3. Inhaled drug treatment for tuberculosis: past progress and future prospects;Hickey;J. Control. Release,2016

4. An insight into advances in developing nanotechnology based therapeutics, drug delivery, diagnostics and vaccines: multidimensional applications in tuberculosis disease management;Chopra;Pharmaceuticals,2023

5. Novel approaches for the treatment of pulmonary tuberculosis;Tan;Pharmaceutics,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhalable chitosan-coated nano-assemblies potentiate niclosamide for targeted abrogation of non-small-cell lung cancer through dual modulation of autophagy and apoptosis;International Journal of Biological Macromolecules;2024-11

2. Breaking barriers: The potential of nanosystems in antituberculosis therapy;Bioactive Materials;2024-09

3. Quality by Design in Pulmonary Drug Delivery: A Review on Dry Powder Inhaler Development, Nanotherapy Approaches, and Regulatory Considerations;AAPS PharmSciTech;2024-08-02

4. Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression;ACS Infectious Diseases;2024-07-22

5. A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals;Drying Technology;2024-06-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3